UBS Group’s Iveda Solutions Warrant IVDAW Stock Holding History

UBS Group’s Portfolio IVDAW Stock Details IVDAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248	Buy	9,903 +3,702	+60%	+$187	﹤0.01%	9966
2026 Q1	$254	Sell	6,201 -10	-0.2%	-$1	﹤0.01%	9997
2025 Q4	$497	Sell	6,211 -18,022	-74%	-$2.81K	﹤0.01%	9932
2025 Q3	$2.91K	Buy	24,233 +2,047	+9%	+$249	﹤0.01%	9113
2025 Q2	$2.88K	Sell	22,186 -7,114	-24%	-$936	﹤0.01%	9411
2025 Q1	$4.28K	Buy	+29,300	New	+$5.25K	﹤0.01%	9122
2023 Q1	–	Sell	-2,584	Closed	-$310	–	9962
2022 Q4	$310	Sell	2,584 -717	-22%	-$99	﹤0.01%	10257
2022 Q3	$1K	Hold	3,301	–	–	﹤0.01%	9972
2022 Q2	$1K	Buy	+3,301	New	+$1.49K	﹤0.01%	9889

Other funds holding IVDAW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

UBS Group's IVDAW Position: Q2 2026 in Review

UBS Group increased its Iveda Solutions Warrant (IVDAW) stake by 60% in Q2 2026, buying an estimated $187 and bringing the position to 9,903 shares worth $248. The position accounts for ﹤0.01% of the portfolio, ranked #9966.

UBS Group first reported a position in IVDAW in Q2 2022 and has held it in 9 quarters since. The position peaked at $4.28K in Q1 2025. 7 funds tracked by Wall St. Rank hold IVDAW as of Q2 2026.

UBS Group held 9,903 shares of Iveda Solutions Warrant worth $248 as of Q2 2026.
UBS Group bought 3,702 Iveda Solutions Warrant shares in Q2 2026, an estimated $187.
Iveda Solutions Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #9966 holding.
UBS Group first reported a position in Iveda Solutions Warrant in Q2 2022 and has held it in 9 quarters since.
UBS Group's Iveda Solutions Warrant position peaked at $4.28K in Q1 2025.
7 funds tracked by Wall St. Rank held Iveda Solutions Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.